Notice2024-30711
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 26, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 247 (Thursday, December 26, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 247 (Thursday, December 26, 2024)]
[Notices]
[Page 105062]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-30711]
[[Page 105062]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and contract proposals and
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications and
contract proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP 2A: SBIR Review Meeting.
Date: February 24, 2025.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract proposals.
Address: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W534, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Ivan Ding, M.D., Health Scientist Administrator,
Division of Extramural Activities, Program and Review Extramural
Staff Training Office, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W534, Rockville, Maryland 20850, 240-276-6444,
<a href="/cdn-cgi/l/email-protection#e7838e89808ea78a868e8bc9898e8fc9808891"><span class="__cf_email__" data-cfemail="4d2924232a240d202c242163232425632a223b">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-4: SBIR Contract Review Meeting.
Date: February 25-26, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Address: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W534, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, Division of Extramural Activities, Program
and Review Extramural Staff Training Office, National Cancer
Institute, NIH, 9609 Medical Center Drive, Room 7W238, Rockville,
Maryland 20850, 240-276-6371, <a href="/cdn-cgi/l/email-protection#badedfd9d6cfdfd0fad7dbd3d694d4d3d294ddd5cc"><span class="__cf_email__" data-cfemail="117574727d64747b517c70787d3f7f78793f767e67">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP 2B: SBIR Review Meeting.
Date: February 25, 2025.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract proposals.
Address: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W534, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Ivan Ding, M.D., Health Scientist Administrator,
Division of Extramural Activities, Program and Review Extramural
Staff Training Office, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W534, Rockville, Maryland 20850, 240-276-6444,
<a href="/cdn-cgi/l/email-protection#95f1fcfbf2fcd5f8f4fcf9bbfbfcfdbbf2fae3"><span class="__cf_email__" data-cfemail="cca8a5a2aba58ca1ada5a0e2a2a5a4e2aba3ba">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP 5A: SBIR Review Meeting.
Date: March 3, 2025.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Address: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W534, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Ivan Ding, M.D., Health Scientist Administrator,
Division of Extramural Activities, Program and Review Extramural
Staff Training Office, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W534, Rockville, Maryland 20850, 240-276-6444,
<a href="/cdn-cgi/l/email-protection#c8aca1a6afa188a5a9a1a4e6a6a1a0e6afa7be"><span class="__cf_email__" data-cfemail="cca8a5a2aba58ca1ada5a0e2a2a5a4e2aba3ba">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP 5B: SBIR Review Meeting.
Date: March 4, 2025.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Address: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W534, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Ivan Ding, M.D., Health Scientist Administrator,
Division of Extramural Activities, Program and Review Extramural
Staff Training Office, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W534, Rockville, Maryland 20850, 240-276-6444,
<a href="/cdn-cgi/l/email-protection#76121f18111f361b171f1a58181f1e58111900"><span class="__cf_email__" data-cfemail="0165686f6668416c60686d2f6f68692f666e77">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Innovative Molecular and Cellular Analysis Technologies.
Date: March 4-5, 2025.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850, 240-276-5460,
<a href="/cdn-cgi/l/email-protection#84eee2e5eae3c4e9e5ede8aaeaedecaae3ebf2"><span class="__cf_email__" data-cfemail="e9838f88878ea984888085c7878081c78e869f">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Assay Validation of High-Quality Markers for Clinical Studies
in Cancer (UH2/UH3).
Date: March 5, 2025.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W552, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Xiaozhong Alex Bao, Ph.D., Scientific Review
Officer, Program Coordination and Referral Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W552, Rockville, Maryland 20850, 240-276-5070,
<a href="/cdn-cgi/l/email-protection#82c0e3edfac2efe3ebeeacecebeaace5edf4"><span class="__cf_email__" data-cfemail="f9bb989681b994989095d7979091d79e968f">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Translational Research Toward Development of a Kaposi Sarcoma
Herpesvirus (KSHV) Vaccine.
Date: March 11, 2025.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W634, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Michael E. Lindquist, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W634, Rockville, Maryland 20850,
<a href="/cdn-cgi/l/email-protection#395450525c175550575d484c504a4d79575051175e564f"><span class="__cf_email__" data-cfemail="4c2125272962202522283d39253f380c222524622b233a">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: December 18, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-30711 Filed 12-23-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 26, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.